Cambridge Cognition Holdings Plc (COG.L)

52,00 0,00 (0,00%) Börsenschluss: 04:03PM BST

Cambridge Cognition Holdings Plc

Tunbridge Court
Tunbridge Lane Bottisham
Cambridge CB25 9TU
United Kingdom
44 1223 810 700
https://www.cambridgecognition.com

Sektor(en): Healthcare
Branche: Health Information Services
Vollzeitmitarbeiter: 80

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Matthew William Stork	CEO & Director	342k	N/A	1968
Mr. Stephen Daniel Symonds	CFO & Executive Director	203,31k	N/A	1975
Mr. John Hammond	Co-Founder	N/A	N/A	N/A
Mr. Nick Taptiklis	Head of Technology Strategy	N/A	N/A	N/A
Ms. Francesca Cormack Ph.D.	Chief Scientist & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Simon Merritt	Marketing and Communications Director	N/A	N/A	N/A
Dr. Lisa Elizabeth Nolan Ph.D.	Vice President Business Development	N/A	N/A	1962
Ms. Nicky Ackerley	Global HR Director	N/A	N/A	N/A
Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D.	Senior Consultant	N/A	N/A	N/A
Prof. Barbara Sahakian FBPsS, FMedSci	Senior Consultant	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Corporate Governance

Cambridge Cognition Holdings Plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.